Abstract
Background Blood culture (BC) sampling is recommended for all suspected sepsis patients prior to antibiotic administration. Here, we aimed to identify barriers and enablers to BC sampling in three Southeast Asian countries.
Methods We conducted a systematic review of studies evaluating barriers/enablers to BC sampling from 1900 to 2020 globally (PROSPERO, CRD42020206557). Using the findings of the systematic review, we developed and conducted a Theoretical Domains Framework (TDF)-based survey with a case scenario question among doctors and final-year medical students in Indonesia, Thailand and Vietnam.
Findings In the systematic review, we identified 6,175 unique records from the databases, of which 25 met the eligibility criteria. Studies were conducted in 37 high-income countries (HICs) and 41 low-and middle-income countries (LMICs). Of 14 TDF domains, three and seven were not assessed in HICs and LMICs by the studies included in the systematic review, respectively. 1,070 medical doctors and 238 final-year medical students completed the survey. The proportion of respondents who would definitely take BC in the case scenario was 89.8% for Thai, 50.5% for Vietnamese and 31.3% for Indonesians (p<0.001). Eight TDF domains were considered key in influencing BC sampling, including ‘no awareness of guideline [TDF-knowledge]’, ‘low priority of BC [TDF-goals]’, ‘no intention to follow guidelines [TDF-intention]’, ‘level of doctors who can order or initiate an order for BC [TDF-social professional role and identity]’, ‘no norms of BC sampling [TDF-social influence]’, ‘perceived cost-effectiveness of BC [TDF-environmental context and resources]’, ‘regulation on cost reimbursement [TDF-behavioural regulation]’ and ‘consequences that discourage BC sampling [TDF-reinforcement].’ However, there was substantial heterogeneity between the countries across most domains.
Conclusions Evidence on barriers and enablers to BC sampling is limited globally. We identified individual, socio-cultural and environmental barriers/enablers to BC sampling across different countries, which represent potential targets for interventions. Context-specific multifaceted interventions at both hospital and policy levels are required to improve diagnostic stewardship practices.
Funding Wellcome Trust, UK (220557/Z/20/Z).
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020206557
Funding Statement
This research was funded by the Wellcome Trust (220557/Z/20/Z). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Oxford University Tropical Research Ethics Committee (OXTREC545-21) and local ethical committees at Iskak Tulungagung Hospital (070/7303/407.206/2021), Prof. Dr. R.D. Kandou Hospital (156/EC/KEPK-KANDOU/IX/2021), Pasar Minggu Hospital (EOCRU/RCH.216/10.2021/1145) in Indonesia, The National Hospital for Tropical Diseases (14HDDD/NDTU) in Vietnam, Faculty of Tropical Medicine, Mahidol University (TMEC21-069), Sunpasitthiprasong Hospital (065/64S) and Chiangrai Prachanukroh Hospital (CR 0032.102/EC023) in Thailand.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All produced in the present study are available upon reasonable request to the corresponding author.
